141 related articles for article (PubMed ID: 33087502)
1. Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis.
Casulleras M; Flores-Costa R; Duran-Güell M; Alcaraz-Quiles J; Sanz S; Titos E; López-Vicario C; Fernández J; Horrillo R; Costa M; de la Grange P; Moreau R; Arroyo V; Clària J
Sci Transl Med; 2020 Oct; 12(566):. PubMed ID: 33087502
[TBL] [Abstract][Full Text] [Related]
2. Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis.
Alcaraz-Quiles J; Casulleras M; Oettl K; Titos E; Flores-Costa R; Duran-Güell M; López-Vicario C; Pavesi M; Stauber RE; Arroyo V; Clària J
Hepatology; 2018 Nov; 68(5):1937-1952. PubMed ID: 30070728
[TBL] [Abstract][Full Text] [Related]
3. Human serum albumin, systemic inflammation, and cirrhosis.
Arroyo V; García-Martinez R; Salvatella X
J Hepatol; 2014 Aug; 61(2):396-407. PubMed ID: 24751830
[TBL] [Abstract][Full Text] [Related]
4. Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution.
Casulleras M; Flores-Costa R; Duran-Güell M; Zhang IW; López-Vicario C; Curto A; Fernández J; Arroyo V; Clària J
Hepatol Commun; 2022 Jun; 6(6):1443-1456. PubMed ID: 35178899
[TBL] [Abstract][Full Text] [Related]
5. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
6. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
Fernández J; Clària J; Amorós A; Aguilar F; Castro M; Casulleras M; Acevedo J; Duran-Güell M; Nuñez L; Costa M; Torres M; Horrillo R; Ruiz-Del-Árbol L; Villanueva C; Prado V; Arteaga M; Trebicka J; Angeli P; Merli M; Alessandria C; Aagaard NK; Soriano G; Durand F; Gerbes A; Gustot T; Welzel TM; Salerno F; Bañares R; Vargas V; Albillos A; Silva A; Morales-Ruiz M; Carlos García-Pagán J; Pavesi M; Jalan R; Bernardi M; Moreau R; Páez A; Arroyo V
Gastroenterology; 2019 Jul; 157(1):149-162. PubMed ID: 30905652
[TBL] [Abstract][Full Text] [Related]
7. Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model.
Maeda H; Minayoshi Y; Ichimizu S; Mizuta Y; Nagasaki T; Matsusaka K; Oshiro S; Oniki K; Saruwatari J; Ishima Y; Watanabe H; Otagiri M; Maruyama T
Biol Pharm Bull; 2020; 43(1):93-101. PubMed ID: 31902937
[TBL] [Abstract][Full Text] [Related]
8. Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.
Wilde B; Katsounas A
Mediators Inflamm; 2019; 2019():7537649. PubMed ID: 30930689
[TBL] [Abstract][Full Text] [Related]
9. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
11. Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils.
József L; Khreiss T; El Kebir D; Filep JG
J Immunol; 2006 Jan; 176(2):1195-202. PubMed ID: 16394009
[TBL] [Abstract][Full Text] [Related]
12. Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling.
Funami K; Matsumoto M; Oshiumi H; Inagaki F; Seya T
Biochem Soc Trans; 2017 Aug; 45(4):929-935. PubMed ID: 28630139
[TBL] [Abstract][Full Text] [Related]
13. The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses.
Murshid A; Borges TJ; Lang BJ; Calderwood SK
Front Immunol; 2016; 7():226. PubMed ID: 27379091
[TBL] [Abstract][Full Text] [Related]
14. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
15. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor-mediated inflammatory responses.
Westphal A; Cheng W; Yu J; Grassl G; Krautkrämer M; Holst O; Föger N; Lee KH
J Exp Med; 2017 Jan; 214(1):227-244. PubMed ID: 27881733
[TBL] [Abstract][Full Text] [Related]
18. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
19. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
[TBL] [Abstract][Full Text] [Related]
20. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
